Hims & Hers Raises $300M in Convertible Notes to Fuel Global Expansion and AI Investments — Hims & Hers Health, Inc.

Event summary

Hims & Hers plans to raise $300M in convertible senior notes due 2032, with an option for an additional $45M.
Proceeds will support international expansion, including the acquisition of Eucalyptus, expected to close mid-2026.
Funds will also accelerate AI-driven platform investments and technology infrastructure.
Notes are senior, unsecured obligations with potential redemption starting June 6, 2029.
Capped call transactions will aim to reduce dilution upon conversion.

The big picture

Hims & Hers is doubling down on its digital health platform with a significant debt raise, targeting both global growth and AI-driven operational improvements. This move aligns with broader industry trends of telehealth expansion and data-driven personalization, but the company's ability to manage debt and execute acquisitions will be critical. The $300M offering underscores the competitive pressure to scale infrastructure while maintaining financial flexibility.

What we're watching

Execution Risk: Whether Hims & Hers can successfully integrate Eucalyptus and scale internationally as planned.
Market Dynamics: How the capped call transactions will impact stock volatility and investor sentiment.
AI Integration: The pace at which AI enhancements will drive cost efficiencies and improve consumer experience.